Genuine Parts Company vs Health Care Select Sector SPDR Fund — how do they compare? Genuine Parts Company trades at $125.04 (market cap $16.65B), while Health Care Select Sector SPDR Fund trades at $161.51. The key difference: Genuine Parts Company pays a 3.51% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Genuine Parts Company nearer its low. Which is the better fit depends on your goals.
| GPC | XLV | |
|---|---|---|
Market Cap | $16.65B | — |
Sector | Consumer Cyclical | — |
52-Week High | $149.26 | $164.48 |
52-Week Low | $92.47 | $129.01 |
Enterprise Value | $22.87B | — |
Dividend Yield | 3.51% | — |
Signals from Pluang's Aura AI — not financial advice
GPC trades at $125.40, up 2.65% with a bullish technical signal. The stock shows mixed fundamentals with a high P/E ratio of 275 but strong gross margins of 36.87%. Recent earnings beat expectations in Q1 2026 after two consecutive misses, with Q2 2026 results expected July 21. Analyst consensus is mixed with 43% buy ratings and a $133 price target, while technical indicators show support at $119-120 and resistance at $122-124.
GPC presents a cautious opportunity with dividend stability but faces profitability challenges. The 70-year dividend growth history provides income appeal, though net margins below 1% and declining cash flow trends warrant monitoring. Upside exists if Q2 earnings beat expectations, but weak profitability and rising debt-to-asset ratios pose significant risks to shareholder value.
XLV trades at $161.47, up 2.01% with a bullish technical signal from moving averages. The healthcare ETF benefits from State Street's upgraded sector outlook and strong performance from holdings like Johnson & Johnson. Technical indicators show support at $156-158 with resistance at $159-161, while RSI readings suggest neutral momentum.
The outlook remains positive as healthcare gains favor for defensive qualities amid market volatility. Key risks include patent expirations and regulatory pressures, but diversified exposure and innovation in biotech/pharma support long-term growth potential. Analyst sentiment favors healthcare for stability and innovation-driven returns.
Trailing returns across standard periods
Latest headlines on both assets
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →